Evidence map›Paper›PMID 36180446›Full record

ArticleNPJ science of learning2022

Teaching resources for the European Open Platform for Prescribing Education (EurOP

Michiel J Bakkum, Bryan J Loobeek, Milan C Richir, Paraskevi Papaioannidou, Robert Likic, Emilio J Sanz, Thierry Christiaens, João N Costa, Lorena Dima, Fabrizio de Ponti and 5 more

Abstract read
In one paragraph

Article in NPJ science of learning, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Michiel J BakkumAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Section Pharmacotherapy, De Boelelaan 1117, 1081 HV, Amsterdam, Netherlands. m.bakkum@amsterdamumc.nl.ORCID http://orcid.org/0000-0003-0928-812X
Bryan J LoobeekAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Section Pharmacotherapy, De Boelelaan 1117, 1081 HV, Amsterdam, Netherlands.
Milan C RichirAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Section Pharmacotherapy, De Boelelaan 1117, 1081 HV, Amsterdam, Netherlands.
Paraskevi PapaioannidouEuropean Association for Clinical Pharmacology and Therapeutics (EACPT) Education Working Group, Frankfurt, Germany.ORCID http://orcid.org/0000-0001-8880-0288
Robert LikicEuropean Association for Clinical Pharmacology and Therapeutics (EACPT) Education Working Group, Frankfurt, Germany.ORCID http://orcid.org/0000-0003-1413-4862
Emilio J SanzEuropean Association for Clinical Pharmacology and Therapeutics (EACPT) Education Working Group, Frankfurt, Germany.ORCID http://orcid.org/0000-0001-6788-4435
Thierry ChristiaensEuropean Association for Clinical Pharmacology and Therapeutics (EACPT) Education Working Group, Frankfurt, Germany.
João N CostaEuropean Association for Clinical Pharmacology and Therapeutics (EACPT) Education Working Group, Frankfurt, Germany.
Lorena DimaEuropean Association for Clinical Pharmacology and Therapeutics (EACPT) Education Working Group, Frankfurt, Germany.
Fabrizio de PontiDepartment of Medical and Surgical Sciences, Pharmacology Unit, Alma Mater Studiorum, University of Bologna, Bologna, Italy.ORCID http://orcid.org/0000-0002-0367-9595
Cornelis KramersDepartment of Internal Medicine and Pharmacology-Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands.
Jeroen van SmedenDivision of education, Centre for Human Drug Research, Leiden, The Netherlands.
Michiel A van Agtmael *Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Section Pharmacotherapy, De Boelelaan 1117, 1081 HV, Amsterdam, Netherlands.
Jelle Tichelaar *Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Section Pharmacotherapy, De Boelelaan 1117, 1081 HV, Amsterdam, Netherlands.
EurOP²E consortium

Funding

EC | Erasmus+ 2020-1-NL01-KA203-083098.
6 · The paper itself

Abstract

The European Open Platform for Prescribing Education (EurOP

Identifiers

PMID36180446
PMCPMC9523648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.